ADVT.US Advantis Corp

Healthcare Pharmaceuticals USA Stocks
0.0000 USD
Close of Nov 18, 2025
Market cap
USD 9.78K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is ADVT.US undervalued?

Graham number

The Graham number of Advantis Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Advantis Corp fundamental analysis

No fundamental analysis for Advantis Corp yet.

Advantis Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Advantis Corp

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.

Full company profile